RADPHARM PYP kit for the preparation of Technetium (99mTc) tin pyrophosphate powder for injection multidose vial Australia - English - Department of Health (Therapeutic Goods Administration)

radpharm pyp kit for the preparation of technetium (99mtc) tin pyrophosphate powder for injection multidose vial

global medical solutions australia pty limited t/a radpharm scientific - sodium pyrophosphate, quantity: 30 mg - injection, powder for - excipient ingredients: stannous chloride - indications as at 25 september: technetium (99mtc) labelled erthrocytes are used in the non invasive evaluation of cardiac ventricular function and heart wall motion.

RADPHARM DTPA kit for production of Technetium (99mTc) pentetate powder for injection multidose vial Australia - English - Department of Health (Therapeutic Goods Administration)

radpharm dtpa kit for production of technetium (99mtc) pentetate powder for injection multidose vial

global medical solutions australia pty limited t/a radpharm scientific - pentetic acid, quantity: 5 mg - injection, powder for - excipient ingredients: stannous chloride - indications as at 25 september 1996: technetium (99mtc) pentetate may be used as a renal perfusion imaging pharmaceutical.

CARDIOLITE Powder for injection Australia - English - Department of Health (Therapeutic Goods Administration)

cardiolite powder for injection

global medical solutions australia pty limited t/a radpharm scientific - tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate, quantity: 1 mg - injection, powder for - excipient ingredients: cysteine hydrochloride; stannous chloride dihydrate; sodium citrate dihydrate; mannitol - technetium (99mtc) sestamibi is indicated for use in conjunction with stress testing as an adjunct in the diagnosis of ischaemic heart disease. in these patients additional information about ventricular function may be derived by using the first pass technique. indications as at 23 november 1999: technetium [99mtc] sestamibi is indicated for use in conjunction with stress testing as an adjunct in the diagnosis of ischaemic heart disease. in these patients additional information about ventricular function may be derived by using the first pass technique. technetium [99mtc] sestamibi is indicated as a second line diagnostic aid to assist in the evaluation of patients for whom mammography is inconclusive.

NEUROLITE bicisate dihydrochloride 0.9mg/mL kit   for the preparation of technetium [99Tc] bicisate Australia - English - Department of Health (Therapeutic Goods Administration)

neurolite bicisate dihydrochloride 0.9mg/ml kit for the preparation of technetium [99tc] bicisate

global medical solutions australia pty limited t/a radpharm scientific - bicisate dihydrochloride, quantity: 0.9 mg - injection, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; monobasic sodium phosphate; water for injections - [99mtc]-bicisate scintigraphy is indicated in the evaluation and localisation of regional perfusion abnormalities in adult patients with the central nervous system disorders of stroke and dementia.

RADPHARM LEUCOCYTE LABELLING KIT injection composite pack Australia - English - Department of Health (Therapeutic Goods Administration)

radpharm leucocyte labelling kit injection composite pack

global medical solutions australia pty limited t/a radpharm scientific - sodium fluoride, quantity: 1 mg/ml - injection, powder for - excipient ingredients: stannous fluoride - indications as at 25 september 1996: technetium (99mtc) labelled leucocytes may be used to image acute inflammation or infection.

RADPHARM MDP kit for the production of Technetium (99mTc) medronate powder for injection multidose vial Australia - English - Department of Health (Therapeutic Goods Administration)

radpharm mdp kit for the production of technetium (99mtc) medronate powder for injection multidose vial

global medical solutions australia pty limited t/a radpharm scientific - medronic acid, quantity: 10 mg - injection, powder for - excipient ingredients: ascorbic acid; stannous chloride - indications as at 25 september 1996: technetium (99mtc) medronate may be used as a skeletal imaging pharmaceutical.

RADPHARM HDP sodium oxidronate 3.15 mg kit for the preparation of technetium (99m Tc) oxidronate for injection Australia - English - Department of Health (Therapeutic Goods Administration)

radpharm hdp sodium oxidronate 3.15 mg kit for the preparation of technetium (99m tc) oxidronate for injection

global medical solutions australia pty limited t/a radpharm scientific - sodium oxidronate, quantity: 3.15 mg - injection, powder for - excipient ingredients: sodium chloride; stannous chloride dihydrate; dilute hydrochloric acid; gentisic acid; sodium hydroxide - technetium [99m tc] sodium oxidronate is a diagnostic skeletal imaging agent to demonstrate areas of altered osteogenesis in adult patients.

DEFINITY perflutren lipid microsphere injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

definity perflutren lipid microsphere injection vial

global medical solutions australia pty limited t/a radpharm scientific - perflutren, quantity: 1.1 mg/ml - injection, suspension - excipient ingredients: sodium chloride; propylene glycol; water for injections; dipalmitoylphosphatidylcholine; n-(methoxy-peg-5000 carbamoyl)-dipalmitoylphosphatidylethanolamine sodium; sodium dipalmitoylphosphatidate; glycerol; dibasic sodium phosphate heptahydrate; monobasic sodium phosphate monohydrate - this medicinal product is for diagnostic use only. definity is indicated for use in patients in contrast-enhanced diagnostic ultrasound imaging to improve the characterization of focal lesions of the liver and kidney. definity is indicated for use in patients with suboptimal echocardiograms to provide opacification of cardiac chambers, improvement of left ventricular endocardial border delineation and assessment of regional wall at both rest and stress.

LANTHEUS GALLIUM(67Ga) CITRATE 74MBq/mL injection  USP Australia - English - Department of Health (Therapeutic Goods Administration)

lantheus gallium(67ga) citrate 74mbq/ml injection usp

global medical solutions australia pty limited - gallium (67ga) citrate, quantity: 74 mbq/ml - injection, solution - excipient ingredients: benzyl alcohol; hydrochloric acid; sodium hydroxide; sodium citrate dihydrate; sodium chloride; water for injections - indications as at 23 december 2003: gallium citrate ga67 injection, u.s.p. may be useful in demonstrating the presence of the following malignancies; hodgkins disease, lymphomas and bronchogenic carcinoma. positive ga67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state.

DRAXIMAGE MAA kit for the preparation of Technetium Tc 99m Albumin Aggregated Injection Australia - English - Department of Health (Therapeutic Goods Administration)

draximage maa kit for the preparation of technetium tc 99m albumin aggregated injection

global medical solutions australia pty limited t/a radpharm scientific - aggregated albumin, quantity: 2.5 mg; stannous chloride dihydrate, quantity: 0.1 mg; sodium chloride, quantity: 1.2 mg; albumin, quantity: 5 mg - powder - excipient ingredients: nitrogen; water for injections - technetium tc 99m albumin aggregated injection is a lung imaging agent which may be used as an adjunct in the evaluation of pulmonary perfusion in adults and paediatric patients. technetium tc 99m albumin aggregated injection may be used in adults as an imaging agent to aid in the evaluation of peritoneovenous (leveen) shunt patency.